(NASDAQ: NVCR) Novocure's forecast annual revenue growth rate of 8.75% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.43%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.07%.
Novocure's revenue in 2025 is $621,711,000.On average, 5 Wall Street analysts forecast NVCR's revenue for 2025 to be $69,278,510,795, with the lowest NVCR revenue forecast at $68,345,153,067, and the highest NVCR revenue forecast at $70,603,852,012. On average, 5 Wall Street analysts forecast NVCR's revenue for 2026 to be $76,496,090,740, with the lowest NVCR revenue forecast at $74,547,098,887, and the highest NVCR revenue forecast at $79,299,731,464.
In 2027, NVCR is forecast to generate $90,503,145,796 in revenue, with the lowest revenue forecast at $81,116,947,298 and the highest revenue forecast at $103,168,805,704.